N. Sawada and J. K. Liao, Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis, Antioxid Redox Signal, vol.20, issue.8, p.23919640, 2014.

O. Adam and U. Laufs, Rac1-mediated effects of HMG-CoA reductase inhibitors (statins) in cardiovascular disease, Antioxid Redox Signal, vol.20, issue.8, p.23919665, 2014.

S. W. Ryter and A. M. Choi, Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation, Transl Res, p.26166253, 2015.

K. Mitani, H. Fujita, Y. Fukuda, A. Kappas, and S. Sassa, The role of inorganic metals and metalloporphyrins in the induction of haem oxygenase and heat-shock protein 70 in human hepatoma cells, Biochem J, vol.290, pp.819-844, 1993.

J. D. Lutton, J. L. Da-silva, S. Moqattash, A. C. Brown, R. D. Levere et al., Differential induction of heme oxygenase in the hepatocarcinoma cell line (Hep3B) by environmental agents, J Cell Biochem, vol.49, issue.3, p.1322919, 1992.

R. Motterlini, R. Foresti, M. Intaglietta, and R. M. Winslow, NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. The American journal of physiology, vol.270, p.8769740, 1996.

R. Foresti, J. E. Clark, C. J. Green, and R. Motterlini, Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions, The Journal of biological chemistry, vol.272, issue.29, pp.18411-18418, 1997.

T. S. Lee and L. Y. Chau, Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice, Nat Med, vol.8, issue.3, p.11875494, 2002.

M. J. Alcaraz, P. Fernandez, and M. I. Guillen, Anti-inflammatory actions of the heme oxygenase-1 pathway, Curr Pharm Des, vol.9, issue.30, pp.2541-51, 2003.

P. J. Murray and T. A. Wynn, Obstacles and opportunities for understanding macrophage polarization, J Leukoc Biol, vol.89, issue.4, p.21248152, 2011.

A. Sica and A. Mantovani, Macrophage plasticity and polarization: in vivo veritas, J Clin Invest, vol.122, issue.3, pp.787-95, 2012.

T. Roszer, Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms, Mediators Inflamm, p.816460, 2015.

M. Nahrendorf and F. K. Swirski, Abandoning M1/M2 for a Network Model of Macrophage Function, Circ Res, vol.119, issue.3, p.27458196, 2016.

V. Vijayan, F. Wagener, and S. Immenschuh, The macrophage heme-heme oxygenase-1 system and its role in inflammation, Biochem Pharmacol, vol.153, p.29452096, 2018.

M. Zhang, K. Nakamura, S. Kageyama, A. O. Lawal, K. W. Gong et al., Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury, JCI Insight, vol.3, p.30282830, 2018.

J. C. Chen, K. C. Huang, and W. W. Lin, HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways, Cell Signal, vol.18, issue.1, p.16214041, 2005.

M. W. Liu, M. X. Su, W. Zhang, L. Wang, and C. Y. Qian, Atorvastatin increases lipopolysaccharide-induced expression of tumour necrosis factor-alpha-induced protein 8-like 2 in RAW264.7 cells, Exp Ther Med, vol.8, issue.1, p.24944625, 2014.

C. A. Mouawad, M. F. Mrad, M. Al-hariri, H. Soussi, E. Hamade et al., Role of nitric oxide and CCAAT/enhancer-binding protein transcription factor in statin-dependent induction of heme oxygenase-1 in mouse macrophages, PLoS One, vol.8, issue.5, p.23717538, 2013.

M. F. Mrad, C. A. Mouawad, M. Al-hariri, A. A. Eid, J. Alam et al., Statins modulate transcriptional activity of heme-oxygenase-1 promoter in NIH 3T3 Cells, J Cell Biochem, vol.113, issue.11, p.22689023, 2012.

X. Q. Wang, N. S. Luo, Z. Q. Salah, Y. Q. Lin, M. N. Gu et al., Atorvastatin Attenuates TNF-alpha Production via Heme Oxygenase-1 Pathway in LPS-stimulated RAW264.7 Macrophages, Biomed Environ Sci, vol.27, issue.10, p.25341814, 2014.

A. Habib, I. Shamseddeen, M. S. Nasrallah, T. A. Antoun, G. Nemer et al., Modulation of COX-2 expression by statins in human monocytic cells, FASEB J, vol.21, issue.8, p.17317725, 2007.

L. Diomede, D. Albani, M. Sottocorno, M. B. Donati, M. Bianchi et al., In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products, Arterioscler Thromb Vasc Biol, vol.21, issue.8, p.11498461, 2001.

Y. Jin, I. Tachibana, Y. Takeda, P. He, S. Kang et al., Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages, PLoS One, vol.8, issue.9, p.24040034, 2013.

M. Hsu, L. Muchova, I. Morioka, R. J. Wong, H. Schroder et al., Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo, Biochem Biophys Res Commun, vol.343, issue.3, p.16563347, 2006.

A. Louvet, F. Teixeira-clerc, M. N. Chobert, V. Deveaux, C. Pavoine et al., Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice, Hepatology, vol.54, issue.4, p.21735467, 2011.

I. Devesa, M. L. Ferrandiz, M. C. Terencio, L. A. Joosten, W. B. Van-den-berg et al., Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis, Arthritis Rheum, vol.52, issue.10, p.16200597, 2005.

U. Laufs, K. Gertz, P. Huang, G. Nickenig, M. Bohm et al., Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice, Stroke, vol.31, issue.10, p.11022078, 2000.

G. A. El-achkar, M. Jouni, M. F. Mrad, T. Hirz, E. Hachem et al., Thiazole derivatives as inhibitors of cyclooxygenases in vitro and in vivo, Eur J Pharmacol, vol.750, p.25617797, 2015.

J. Lodder, T. Denaes, M. N. Chobert, J. Wan, J. El-benna et al., Macrophage autophagy protects against liver fibrosis in mice, Autophagy, vol.11, issue.8, p.26061908, 2015.

J. Wan, M. Benkdane, F. Teixeira-clerc, S. Bonnafous, A. Louvet et al., M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease, Hepatology, vol.59, issue.1, p.23832548, 2014.

M. J. Alcaraz, A. Habib, C. Creminon, A. M. Vicente, M. Lebret et al., Heme oxygenase-1 induction by nitric oxide in RAW 264.7 macrophages is upregulated by a cyclo-oxygenase-2 inhibitor, Biochim Biophys Acta, vol.1526, issue.1, p.11287117, 2001.

M. J. Alcaraz, A. Habib, M. Lebret, C. Creminon, S. Levy-toledano et al., Enhanced expression of haem oxygenase-1 by nitric oxide and antiinflammatory drugs in NIH 3T3 fibroblasts, Br J Pharmacol, vol.130, issue.1, p.10780998, 2000.

C. A. Rouzer and L. J. Marnett, Cyclooxygenases: structural and functional insights, J Lipid Res, vol.50, p.18952571, 2009.

U. Laufs, L. Fata, V. Plutzky, J. Liao, and J. K. , Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors, Circulation, vol.97, issue.12, pp.1129-1164, 1998.

F. Franzoni, A. Quinones-galvan, F. Regoli, E. Ferrannini, and F. Galetta, A comparative study of the in vitro antioxidant activity of statins, International journal of cardiology, vol.90, issue.2-3, pp.317-338, 2003.

A. Iwata, R. Shirai, H. Ishii, H. Kushima, S. Otani et al., Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells, Clinical and experimental immunology, vol.168, issue.2, 2012.

J. C. Chen, K. C. Huang, B. Wingerd, W. T. Wu, and W. W. Lin, HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/ EBPbeta, Exp Cell Res, vol.301, issue.2, p.15530865, 2004.

Y. Pei, P. Ma, X. Wang, W. Zhang, X. Zhang et al., Rosuvastatin attenuates monocrotalineinduced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism, Eur J Pharmacol, vol.666, issue.1-3, p.21641341, 2011.

M. Pelat, C. Dessy, P. Massion, J. P. Desager, O. Feron et al., Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/-mice in vivo, Circulation, vol.107, p.12719275, 2003.

L. Muchova, R. J. Wong, M. Hsu, I. Morioka, L. Vitek et al., Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. Canadian journal of physiology and pharmacology, vol.85, p.17901890, 2007.

A. M. Vicente, M. I. Guillin, and M. J. Alcaraz, Participation of heme oxygenase-1 in a model of acute inflammation, Exp Biol Med (Maywood), vol.228, issue.5, pp.514-520, 2003.

F. Sallusto and M. Baggiolini, Chemokines and leukocyte traffic, Nature immunology, vol.9, issue.9, p.18711431, 2008.

B. Rabe, A. Chalaris, U. May, G. H. Waetzig, D. Seegert et al., Transgenic blockade of interleukin 6 transsignaling abrogates inflammation, Blood, vol.111, issue.3, p.17989316, 2008.

R. Brines, L. Catalan, and M. J. Alcaraz, Myeloid Heme Oxygenase-1 Regulates the Acute Inflammatory Response to Zymosan in the Mouse Air Pouch, p.5053091, 2018.

M. I. Guillen, J. Megias, V. Clerigues, F. Gomar, and M. J. Alcaraz, The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes, Rheumatology (Oxford), vol.47, issue.9, pp.1323-1331, 2008.

J. Megias, J. Busserolles, and M. J. Alcaraz, The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells, Br J Pharmacol, vol.150, issue.8, p.17339836, 2007.

L. Ibanez, M. J. Alcaraz, N. Maicas, D. Guede, J. R. Caeiro et al., Downregulation of the inflammatory response by CORM-3 results in protective effects in a model of postmenopausal arthritis, Calcif Tissue Int, vol.91, issue.1, p.22644323, 2012.

S. Lancel, D. Montaigne, X. Marechal, C. Marciniak, S. M. Hassoun et al., Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome, PLoS One, vol.7, issue.8, p.22870253, 2012.

K. Kramkowski, A. Leszczynska, A. Mogielnicki, S. Chlopicki, A. Fedorowicz et al., Antithrombotic properties of water-soluble carbon monoxide-releasing molecules, Arterioscler Thromb Vasc Biol, vol.32, issue.9, p.22772756, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00732395

E. K. Patterson, D. D. Fraser, A. Capretta, R. F. Potter, and G. Cepinskas, Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/ dysfunction, Free Radic Biol Med, vol.70, p.24583458, 2014.

P. Urquhart, G. Rosignoli, D. Cooper, R. Motterlini, and M. Perretti, Carbon monoxide-releasing molecules modulate leukocyte-endothelial interactions under flow, J Pharmacol Exp Ther, vol.321, issue.2, p.17289832, 2007.

N. Wu, R. Q. Li, and L. Li, SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway, Biochem Biophys Res Commun, vol.501, issue.2, p.29567472, 2018.

D. Garcia-santos, A. Hamdi, Z. Saxova, C. Fillebeen, K. Pantopoulos et al., Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a beta-thalassemia mouse model, Blood, vol.131, issue.2, p.29180398, 2018.

D. A. Tulis, D. W. Peyton, K. J. Evans, A. J. Schafer, and A. I. , Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries, Atherosclerosis, vol.155, issue.1, p.11223432, 2001.

T. Kaizu, T. Tamaki, M. Tanaka, Y. Uchida, S. Tsuchihashi et al., Preconditioning with tinprotoporphyrin IX attenuates ischemia/reperfusion injury in the rat kidney, Kidney Int, vol.63, issue.4, p.12631355, 2003.

A. Uc, K. J. Reszka, G. R. Buettner, and J. B. Stokes, Tin protoporphyrin induces intestinal chloride secretion by inducing light oxidation processes, Am J Physiol Cell Physiol, vol.292, issue.5, p.17215323, 2007.